Virtus ETF Advisers LLC - Q1 2018 holdings

$115 Million is the total value of Virtus ETF Advisers LLC's 246 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 25.9% .

 Value Shares↓ Weighting
FTEC SellFIDELITYmsci info tech i$3,216,000
-8.2%
62,005
-11.6%
2.79%
-36.5%
VPU SellVANGUARD WORLD FDSutilities etf$2,554,000
-5.1%
22,845
-1.0%
2.22%
-34.4%
NKTR SellNEKTAR THERAPEUTICS$1,595,000
+58.1%
15,011
-11.1%
1.38%
+9.3%
ONCE SellSPARK THERAPEUTICS INC$1,333,000
+22.3%
20,024
-5.5%
1.16%
-15.4%
ENTA SellENANTA PHARMACEUTICALS INC$1,263,000
+22.7%
15,613
-10.9%
1.10%
-15.1%
MNTA SellMOMENTA PHARMACEUTICALS INC$1,243,000
+22.8%
68,484
-5.6%
1.08%
-15.1%
SRPT SellSAREPTA THERAPEUTICS INC$1,216,000
+22.1%
16,409
-8.3%
1.06%
-15.6%
LGND SellLIGAND PHARMACEUTICALS INC$1,118,000
+14.0%
6,771
-5.4%
0.97%
-21.2%
RDUS SellRADIUS HEALTH INC$1,115,000
+6.8%
31,013
-5.6%
0.97%
-26.2%
MDCO SellMEDICINES CO$1,096,000
+13.8%
33,271
-5.5%
0.95%
-21.3%
VNDA SellVANDA PHARMACEUTICALS INC$1,079,000
+4.7%
64,040
-5.6%
0.94%
-27.7%
NBIX SellNEUROCRINE BIOSCIENCES INC$1,070,000
+1.0%
12,899
-5.5%
0.93%
-30.2%
VDE SellVANGUARD WORLD FDSenergy etf$1,053,000
-44.6%
11,398
-40.6%
0.91%
-61.7%
ACOR SellACORDA THERAPEUTICS INC$1,032,000
+4.1%
43,653
-5.5%
0.90%
-28.1%
VRTX SellVERTEX PHARMACEUTICALS INC$1,032,000
+1.0%
6,334
-7.1%
0.90%
-30.2%
DVAX SellDYNAVAX TECHNOLOGIES CORP$951,000
+0.2%
47,898
-5.6%
0.82%
-30.7%
GILD SellGILEAD SCIENCES INC$946,000
-0.6%
12,546
-5.6%
0.82%
-31.3%
RTRX SellRETROPHIN INC$935,000
+0.2%
41,803
-5.6%
0.81%
-30.7%
SGEN SellSEATTLE GENETICS INC$915,000
-7.6%
17,480
-5.5%
0.79%
-36.1%
IRWD SellIRONWOOD PHARMACEUTICALS INC$911,000
-2.8%
59,014
-5.6%
0.79%
-32.8%
ICPT SellINTERCEPT PHARMACEUTICALS IN$903,000
-0.6%
14,681
-5.5%
0.78%
-31.3%
HALO SellHALOZYME THERAPEUTICS INC$898,000
-8.5%
45,820
-5.3%
0.78%
-36.7%
BMRN SellBIOMARIN PHARMACEUTICAL INC$836,000
-14.1%
10,311
-5.5%
0.72%
-40.6%
KERX SellKERYX BIOPHARMACEUTICALS INC$814,000
-16.9%
199,089
-5.5%
0.71%
-42.6%
REGN SellREGENERON PHARMACEUTICALS$810,000
-14.7%
2,352
-6.9%
0.70%
-41.0%
TBPH SellTHERAVANCE BIOPHARMA INC$800,000
-17.9%
32,989
-5.6%
0.69%
-43.2%
INCY SellINCYTE CORP$795,000
-17.8%
9,537
-6.5%
0.69%
-43.1%
BIIB SellBIOGEN INC$774,000
-18.8%
2,826
-5.5%
0.67%
-43.8%
IONS SellIONIS PHARMACEUTICALS INC$775,000
-17.2%
17,582
-5.5%
0.67%
-42.8%
LXRX SellLEXICON PHARMACEUTICALS INC$770,000
-18.0%
89,845
-5.5%
0.67%
-43.3%
EXEL SellEXELIXIS INC$764,000
-31.2%
34,479
-5.6%
0.66%
-52.4%
UTHR SellUNITED THERAPEUTICS CORP DEL$754,000
-28.2%
6,708
-5.5%
0.65%
-50.4%
CLVS SellCLOVIS ONCOLOGY INC$745,000
-26.6%
14,103
-5.5%
0.65%
-49.3%
CELG SellCELGENE CORP$742,000
-19.3%
8,314
-5.6%
0.64%
-44.1%
TSRO SellTESARO INC$651,000
-34.6%
11,391
-5.3%
0.56%
-54.8%
PTLA SellPORTOLA PHARMACEUTICALS INC$627,000
-36.6%
19,203
-5.5%
0.54%
-56.2%
PBYI SellPUMA BIOTECHNOLOGY INC$621,000
-35.0%
9,129
-5.5%
0.54%
-55.0%
OMER SellOMEROS CORP$528,000
-45.7%
47,276
-5.6%
0.46%
-62.5%
ESRX SellEXPRESS SCRIPTS HLDG CO$41,000
-28.1%
598
-22.1%
0.04%
-50.0%
HD SellHOME DEPOT INC$40,000
-27.3%
226
-22.3%
0.04%
-49.3%
CI SellCIGNA CORPORATION$34,000
-39.3%
203
-25.9%
0.03%
-57.1%
NFLX SellNETFLIX INC$35,000
+34.6%
117
-14.0%
0.03%
-9.1%
ETFC SellE TRADE FINANCIAL CORP$28,000
-9.7%
510
-19.3%
0.02%
-38.5%
SCHW SellSCHWAB CHARLES CORP NEW$28,000
-20.0%
532
-20.8%
0.02%
-45.5%
TROW SellPRICE T ROWE GROUP INC$27,000
-6.9%
248
-8.8%
0.02%
-36.1%
INFY SellINFOSYS LTDsponsored adr$25,000
-7.4%
1,417
-14.6%
0.02%
-35.3%
CA SellCA INC$24,000
-35.1%
719
-36.0%
0.02%
-54.3%
CTXS SellCITRIX SYS INC$20,000
-4.8%
212
-10.2%
0.02%
-34.6%
COP SellCONOCOPHILLIPS$20,000
-31.0%
335
-37.0%
0.02%
-52.8%
GGB SellGERDAU S Aspon adr rep pfd$17,000
+21.4%
3,552
-6.7%
0.02%
-16.7%
C SellCITIGROUP INC$16,000
-57.9%
242
-52.8%
0.01%
-70.8%
RF SellREGIONS FINL CORP NEW$16,000
-33.3%
841
-38.3%
0.01%
-53.3%
J SellJACOBS ENGR GROUP INC DEL$15,000
-21.1%
256
-11.1%
0.01%
-45.8%
WU SellWESTERN UN CO$15,000
-11.8%
776
-13.4%
0.01%
-38.1%
WMT SellWAL-MART STORES INC$13,000
-74.0%
144
-71.5%
0.01%
-82.5%
BKR SellBAKER HUGHES A GE COcl a$13,000
-31.6%
465
-23.5%
0.01%
-54.2%
F SellFORD MTR CO DEL$13,000
-51.9%
1,216
-44.2%
0.01%
-67.6%
VIPS SellVIPSHOP HLDGS LTDsponsored adr$11,000
-47.6%
681
-62.4%
0.01%
-61.5%
PVH SellPVH CORP$12,000
-36.8%
81
-40.4%
0.01%
-58.3%
XRX SellXEROX CORP$10,000
-23.1%
355
-20.8%
0.01%
-43.8%
MNKKQ ExitMALLINCKRODT PUB LTD CO$0-224
-100.0%
-0.01%
L100PS ExitARCONIC INC$0-368
-100.0%
-0.01%
SPLK ExitSPLUNK INC$0-164
-100.0%
-0.02%
GPS ExitGAP INC DEL$0-440
-100.0%
-0.02%
NOV ExitNATIONAL OILWELL VARCO INC$0-424
-100.0%
-0.02%
COG ExitCABOT OIL & GAS CORP$0-532
-100.0%
-0.02%
WYNN ExitWYNN RESORTS LTD$0-88
-100.0%
-0.02%
TMUS ExitT MOBILE US INC$0-252
-100.0%
-0.02%
SBAC ExitSBA COMMUNICATIONS CORP NEWcl a$0-100
-100.0%
-0.02%
DXC ExitDXC TECHNOLOGY CO$0-184
-100.0%
-0.02%
CMA ExitCOMERICA INC$0-212
-100.0%
-0.02%
COL ExitROCKWELL COLLINS INC$0-140
-100.0%
-0.02%
FANG ExitDIAMONDBACK ENERGY INC$0-148
-100.0%
-0.02%
NOC ExitNORTHROP GRUMMAN CORP$0-68
-100.0%
-0.03%
SHW ExitSHERWIN WILLIAMS CO$0-52
-100.0%
-0.03%
MCK ExitMCKESSON CORP$0-168
-100.0%
-0.03%
AMT ExitAMERICAN TOWER CORP NEW$0-188
-100.0%
-0.03%
NVDA ExitNVIDIA CORP$0-148
-100.0%
-0.04%
JUNO ExitJUNO THERAPEUTICS INC$0-7,860
-100.0%
-0.45%
RXDX ExitIGNYTA INC$0-22,936
-100.0%
-0.77%
UPW ExitPROSHARES TR$0-23,700
-100.0%
-1.40%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-05-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VERTEX PHARMACEUTICALS INC31Q3 20231.7%
REGENERON PHARMACEUTICALS31Q3 20231.8%
INCYTE CORP31Q3 20232.1%
ENANTA PHARMACEUTICALS INC31Q3 20232.2%
EXELIXIS INC31Q3 20231.8%
VANDA PHARMACEUTICALS INC31Q3 20231.7%
IRONWOOD PHARMACEUTICALS INC31Q3 20232.0%
LIGAND PHARMACEUTICALS INC31Q3 20231.5%
GILEAD SCIENCES INC31Q3 20231.6%
HALOZYME THERAPEUTICS INC31Q3 20231.7%

View Virtus ETF Advisers LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-15
13F-HR2023-11-07
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-16
13F-HR2022-02-14

View Virtus ETF Advisers LLC's complete filings history.

Compare quarters

Export Virtus ETF Advisers LLC's holdings